Amy M. Autry, MD
Obstetrics & Gynecology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Autry’s office at (415) 885-7788 to ask if they take your plan before you enroll.
California Medical Board record
Licence G70559 · Current
Licensed to practise in California · since 2001 · expires 2027-05-31 · Bowman Gray School of Medicine of Wake Forest University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Obstetrics and Gynecology - Obstetrics and Gynecology
Medicaid work
$1,480,259 in 2024
Medicaid paid $1,480,259 for 14,180 billed services this clinician did in 2024, up to 152 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,166 | $429,723 |
| Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | 825 | $376,823 |
| Etonogestrel (contraceptive) implant system, including implant and supplies | 166 | $207,195 |
| Short return visit | 2,643 | $125,358 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 555 | $50,709 |
| Insertion, drug-delivery implant (ie, bioresorbable, biodegradable, non-biodegradable) | 176 | $44,056 |
| Mifepristone, oral, 200 mg | 804 | $40,494 |
| Contraceptive pills for bc | 249 | $36,270 |
| Insertion of intrauterine device (IUD) | 301 | $27,634 |
| INDUCED ABORTION DILATION AND CURETTAGE | 160 | $25,824 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 99 | $25,568 |
| Removal, implantable contraceptive capsules | 281 | $19,046 |
| 2024 | 14,180 | 40 | 152 | $1,480,259 |
| 2023 | 377 | 7 | 35 | $53,910 |
| 2022 | 113 | 5 | 18 | $4,843 |
| 2019 | 13 | 1 | 13 | $433 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 147 | $51,922 |
| INDUCED ABORTION DILATION AND CURETTAGE | 25 | $1,366 |
| Short return visit (20+ min) | 102 | $187 |
| Ultrasound, pregnant uterus, real time with image documentation, limited (eg, fetal heart beat, placental location, fetal position and/or qualitative amniotic fluid volume), 1 or more fetuses | 25 | $126 |
| Short return visit | 15 | $117 |
| Contraceptive supply, condom, male, each | 46 | $104 |
| Screening performed and negative | 17 | $87 |
2022
| Clinic visit/encounter, all-inclusive | 14 | $4,214 |
| Unclassified drugs | 38 | $233 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 15 | $233 |
| Short return visit | 14 | $97 |
| Contraceptive supply, condom, male, each | 32 | $66 |
2019
| OFF/OP EST MAY X REQ PHY/QHP | 13 | $433 |
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 34 Part D prescriptions in 2022. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2022 | 34 | 15 | 0% (0) | None | $4,176 |
| 2021 | 47 | 18 | None | None | $5,322 |
| 2020 | 59 | 24 | 0% (0) | None | $7,443 |
| 2019 | 75 | 31 | None | 20% | $7,955 |
| 2018 | 102 | 22 | 0% (0) | 25% | $7,571 |
| 2017 | 72 | 28 | 0% (0) | 21% | $10,483 |
| 2016 | 25 | 12 | None | 56% | $7,658 |
| 2015 | 40 | 13 | None | 38% | $2,987 |
| 2014 | 33 | 16 | 0% (0) | None | $5,520 |
| 2013 | 97 | 29 | 0% (0) | 40% | $11,302 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2021: 1 drug
| Estradiol | 19 | $2,670 | $141 |
2020: 2 drugs
| Norethindrone Acetate | 11 | $2,509 | $228 |
| Estradiol | 17 | $1,731 | $102 |
2019: 2 drugs
| Estradiol | 24 | $1,872 | $78 |
| Norethindrone | 11 | $133 | $12 |
2018: 5 drugs
| Estradiol | 15 | $956 | $64 |
| Betamethasone Dipropionate | 12 | $939 | $78 |
| Progesterone | 14 | $577 | $41 |
| Clotrimazole | 12 | $214 | $18 |
| Norethindrone | 12 | $107 | $9 |
2017: 1 drug
| Estradiol | 19 | $1,298 | $68 |
2013: 2 drugs
| Vesicare | 14 | $3,013 | $215 |
| Estradiol | 13 | $168 | $13 |
Money from drug and device companies
$30 in 2023
A payment is not proof that care is biased.
| Medicines360 | Liletta | $30 | 1 payment
|
See the published payment
| Medicines360 | Consulting · 2023-01-18 | Liletta | $30 |
Professional record
- NPI
- 1851335624
- Licence
- CA G70559California G70559: Current · expires 2027-05-31
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G705590
- Taxonomy
- Federal specialty code 207V00000X (207V00000X); Federal specialty code 207VG0400X (207VG0400X); Federal specialty code 207VX0000X (207VX0000X)
- Mailing address
- 1635 Divisadero Street, Suite 625, Box 1821, San Francisco, CA, 94143
- NPI first listed
- 2006-06-15
- NPI last updated
- 2022-03-01
- NPI record certified
- 2022-03-01
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2823 Fresno St, Fresno, CA, 93721